Terug
Ook genoteerd als
CPCAF
OTC
Dagbereik
€ 7,80
€ 7,85
52-Weeksbereik
€ 5,48
€ 9,10
Volume
1.010
50D / 200D Gem.
€ 8,11
/
€ 7,41
Vorige Slotkoers
€ 7,90
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Industrials sector mediaan (896 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 1,0 | 13,8 |
| P/B | 0,2 | 1,9 |
| ROE % | 19,2 | 11,4 |
| Net Margin % | 9,3 | 6,5 |
| Rev Growth 5Y % | 26,5 | 8,3 |
| D/E | 1,0 | 0,6 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 8,10
€ 7,44 – € 8,59
|
135,64B | 1 |
| FY2027 |
€ 7,80
€ 7,17 – € 8,27
|
126,03B | 1 |
| FY2026 |
€ 6,78
€ 6,23 – € 7,19
|
120,69B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-11 | N/A | € 0,68 | — |
| 2025-03-13 | N/A | € 0,11 | — |
| 2024-08-07 | N/A | € 0,06 | — |
| 2024-03-13 | N/A | € 0,10 | — |
| 2023-06-30 | N/A | € 0,07 | — |
| 2022-12-31 | N/A | -€ 0,03 | — |
| 2022-06-30 | N/A | -€ 0,10 | — |
| 2021-12-31 | N/A | € 0,04 | — |
Dividend History
4 yr streakYield
0,06%
Payout Ratio
0,41%
Growth (3Y)
23,64%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 01, 2026 | May 18, 2026 | € 0,39 | 6,36% |
| Sep 04, 2025 | Oct 20, 2025 | € 0,11 | 5,97% |
| Apr 02, 2025 | May 19, 2025 | € 0,30 | 6,39% |
| Sep 05, 2024 | Oct 21, 2024 | € 0,11 | 7,39% |
| Apr 02, 2024 | May 13, 2024 | € 0,25 | 4,83% |
| Aug 12, 2020 | Aug 20, 2020 | € 0,22 | 5,56% |
| Sep 03, 2019 | Oct 15, 2019 | € 0,10 | 3,31% |
| Apr 01, 2019 | May 20, 2019 | € 0,11 | 1,93% |
| Sep 04, 2018 | Oct 15, 2018 | € 0,06 | 1,11% |
| Apr 02, 2018 | May 14, 2018 | € 0,03 | 0,33% |
| Sep 02, 2016 | Oct 14, 2016 | € 0,03 | 2,79% |
| Apr 04, 2016 | May 16, 2016 | € 0,17 | 4,02% |
| Sep 04, 2015 | Oct 15, 2015 | € 0,17 | 3,89% |
| Apr 06, 2015 | May 18, 2015 | € 0,17 | 1,97% |
| Sep 04, 2014 | Oct 16, 2014 | € 0,06 | 1,82% |
| Mar 31, 2014 | May 19, 2014 | € 0,10 | 1,54% |
| Sep 03, 2013 | Oct 15, 2013 | € 0,04 | 1,04% |
| Mar 28, 2013 | May 13, 2013 | € 0,05 | 0,60% |
| Mar 29, 2012 | May 14, 2012 | € 0,22 | 9,03% |
| Sep 02, 2011 | Oct 13, 2011 | € 0,12 | 6,22% |
Belangrijkste Punten
Revenue grew 26,45% annually over 5 years — strong growth
ROE of 19,20% — decent returns on equity
Generating 15,90B in free cash flow
P/E of 0,97 — trading at a low valuation
PEG of 0,70 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 14,76%
Groei
Revenue Growth (5Y)
26,45%
Revenue (1Y)11,69%
Earnings (1Y)9,32%
FCF Growth (3Y)-9,95%
Kwaliteit
Return on Equity
19,20%
ROIC8,84%
Net Margin9,27%
Op. Margin12,05%
Veiligheid
Debt / Equity
0,98
Current Ratio0,38
Interest Coverage4,44
Waardering
P/E Ratio
0,97
Forward P/E1,16
P/B Ratio0,17
EV/EBITDA4,08
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,69% | Revenue Growth (3Y) | 11,07% |
| Earnings Growth (1Y) | 9,32% | Earnings Growth (3Y) | 5,08% |
| Revenue Growth (5Y) | 26,45% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 116,57B | Net Income (TTM) | 10,81B |
| ROE | 19,20% | ROA | 6,11% |
| Gross Margin | 17,55% | Operating Margin | 12,05% |
| Net Margin | 9,27% | Free Cash Flow (TTM) | 15,90B |
| ROIC | 8,84% | FCF Growth (3Y) | -9,95% |
| Safety | |||
| Debt / Equity | 0,98 | Current Ratio | 0,38 |
| Interest Coverage | 4,44 | ||
| Dividends | |||
| Dividend Yield | 0,06% | Payout Ratio | 0,41% |
| Dividend Growth (3Y) | 23,64% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 4 yrs | ||
| Valuation | |||
| P/E Ratio | 0,97 | Forward P/E | 1,16 |
| P/B Ratio | 0,17 | P/S Ratio | 0,09 |
| PEG Ratio | 0,70 | Forward PEG | N/A |
| EV/EBITDA | 4,08 | Fwd EV/EBITDA | 2,24 |
| Forward P/S | 0,09 | Fwd Earnings Yield | 86,21% |
| FCF Yield | 151,54% | ||
| Market Cap | 10,49B | Enterprise Value | 57,30B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 116,57B | 104,37B | 94,49B | 51,04B | 45,59B |
| Net Income | 10,81B | 9,89B | 9,79B | -6,62B | -5,53B |
| EPS (Diluted) | 8,10 | 6,65 | 6,30 | -5,60 | -4,75 |
| Gross Profit | 20,46B | 32,58B | 20,70B | 20,41B | 3,17B |
| Operating Income | 14,05B | 13,93B | 15,13B | 3,47B | -1,44B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 177,03B | 171,24B | 174,12B | 180,91B | 196,63B |
| Total Liabilities | 116,92B | 118,74B | 114,08B | 117,03B | 124,38B |
| Shareholders' Equity | 60,10B | 52,50B | 60,03B | 63,88B | 72,24B |
| Total Debt | 59,10B | 68,48B | 68,29B | 77,11B | 89,85B |
| Cash & Equivalents | 12,29B | 5,44B | 7,89B | 7,34B | 8,57B |
| Current Assets | 22,53B | 19,25B | 22,75B | 26,34B | 28,90B |
| Current Liabilities | 59,04B | 50,24B | 45,49B | 43,40B | 43,14B |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recente Activiteit
Uitgestapt
Contrarian Investing (David Dreman)
Mar 26, 2026
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Lower Risk
Mar 24, 2026